About Us
Gems Biogenics International Ltd, Mauritius
Gems Biogenics is strategically entering the Mauritius pharmaceutical market with a clear mission: to provide highly potent and effective pharmaceutical formulations with unique compositions at affordable prices, enhancing healthcare affordability. By targeting key segments such as neuro diabetes, cardiovascular health, antimicrobials, proton pump inhibitors, multivitamins, and antioxidants, the company aims to address critical healthcare needs.
The senior management team at Gems Biogenics brings a wealth of experience, with over 100 years of cumulative expertise from renowned organizations including Pfizer, Novartis, Aventis, Johnson Matthey, Ranbaxy, Alembic, Elder, Mankind, Aristo, and Alkem. This seasoned leadership is well-equipped to navigate the complexities of the pharmaceutical market, ensuring strategic alignment with healthcare affordability, market demands, and regulatory standards while developing innovative pharmaceutical formulations.
Committed to enhancing healthcare affordability, Gems Biogenics aims to make a significant impact on the pharmaceutical market in the Indian Ocean region and East Africa. The company envisions substantial growth within the next three years by leveraging its expertise in innovative pharmaceutical formulations and its deep understanding of the dynamic pharmaceutical sector to expand its footprint and contribute meaningfully to the well-being of the population across the region.
Gems Biogenics International Ltd, based in Mauritius, is strategically positioned to serve as a vital hub for pharmaceutical distribution across Africa. With an established operational presence and deep-rooted networks, we maintain strong connectivity across Eastern, Western, and Southern Africa, offering seamless access to over 20 key markets in the region. Our proximity to these markets, combined with our regulatory experience and on-ground relationships, makes us an ideal partner for introducing high-value, low-volume pharmaceutical formulations. Whether launching specialty therapies or driving market-specific strategies, our infrastructure and regional expertise ensure efficient and compliant market entry. We prioritize healthcare affordability, quality, and long-term impact in all our initiatives. Moreover, we have all the necessary regulatory clearances to make, store, and sell pharmaceutical products in Mauritius.